Posted by Michael Wonder on 31 Jan 2019
Net drug prices are falling, even as list prices increase
30 January 2019 - The net prices of drugs are falling even while list prices increase, as big pharma companies are offering more rebates—or discounts—to middlemen.
Companies are incentivised to give prescription managers rebates so that their drugs will be given perks like lower patient co-pays, The Wall Street Journal reports. These rising rebates means the overall net cost of drugs is going down.
This is despite the fact that rising prices have been a chronic issue in the U.S.: just after the new year, three dozen drug makers raised prices on more than 250 prescription drugs.
